In the wake of the increase in Current Liabilities in the fourth quarter 2011, Quick Ratio fell to 1.6 a new company low.

Within Medical Equipment & Supplies industry 67 other companies have achieved higher Quick Ratio than Daxor in fourth quarter 2011. While Quick Ratio total ranking in the fourth quarter 2011 has deteriorated compared to the prior quarter from 0 to 989.

Explain Quick Ratio?
How much Cash & cash equivalents DXR�s has?
What are DXR�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DXR Quick Ratio	(Dec 31 2011) Q4	(Sep 30 2011) Q3	(Jun 30 2011) Q2	(Dec 31 2010) Q3	Q2
Y / Y Current Liabilities Change	-	-	-	-	-
Y / Y Cash & cash equivalent Change	-	-	-	-	-
Quick Ratio MRQ	1.6	1.6	1.79	1.87	-
DXR's Total Ranking	# 989	# 0	#	#	#
Seq. Current Liabilities Change	201.16 %	28.34 %	-24.38 %	-	-
Seq. Cash & cash equivalent Change	201.82 %	14.72 %	-27.63 %	-	-

Quick Ratio fourth quarter 2011 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 68
Healthcare Sector	# 261
Overall Market	# 989

Quick Ratio Statistics
High	Average	Low
1.6	1.6	1.6
(Dec 31 2011)

Financial Statements
Daxor's Current Liabilities	$ 49 Millions	Visit DXR's Balance sheet
Daxor's Cash & cash equivalent	$ 79 Millions	Visit DXR's Balance sheet
Source of DXR's Sales		Visit DXR's Sales by Geography

Cumulative Daxor's Quick Ratio

DXR's Quick Ratio for the trailling 12 Months

DXR Quick Ratio	(Dec 31 2011) 12 Months	(Sep 30 2011) 12 Months	(Jun 30 2011) 12 Months	(Dec 31 2010) 12 Months	12 Months
Y / Y Current Liabilities TTM Growth	-	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	-	-	-	-	-
Quick Ratio TTM	1.68	1.75	1.84	1.87	-
Total Ranking TTM	#	#	#	#
Seq. Current Liabilities TTM Growth	107.19 %	55.26 %	75.62 %	-	-
Seq. Cash & cash equivalent TTM Growth	98.11 %	48.16 %	72.37 %	-	-

Quick ratio ranking by company, industry and sector >> Back to DXR Financial Strength Comparisons >> Go to Compare DXR Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2011 to $49.26 millions, cumulative Quick Ratio decreased to 1.68 above the DXR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 67 other companies have achieved higher Quick Ratio than Daxor. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents DXR�s has?
What are DXR�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 68
Healthcare Sector	# 261
Within the Market	# 989

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.6	1.6	1.6
(Dec 31 2011)

Companies with similar Quick Ratio in the quarter ending Dec 31 2011, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2011 MRQ Cash & cash equivalent	Dec 31 2011 MRQ Current Liabilities
Retractable Technologies Inc	4.30	$ 25.673 Millions	$ 5.967 Millions
Axogen inc	4.06	$ 8.191 Millions	$ 2.020 Millions
Viveve Medical Inc	4.00	$ 2.585 Millions	$ 0.647 Millions
Neuroone Medical Technologies Corp	3.96	$ 0.014 Millions	$ 0.004 Millions
Abiomed Inc	3.90	$ 69.574 Millions	$ 17.860 Millions
Microbot Medical Inc	3.87	$ 16.592 Millions	$ 4.293 Millions
Star Equity Holdings Inc	3.64	$ 30.646 Millions	$ 8.414 Millions
Delcath Systems Inc	3.48	$ 30.757 Millions	$ 8.837 Millions
Neurometrix Inc	3.42	$ 10.290 Millions	$ 3.013 Millions
Haemonetics Corporation	3.36	$ 228.861 Millions	$ 68.132 Millions
Insulet Corporation	3.36	$ 93.955 Millions	$ 27.995 Millions
Intuitive Surgical Inc	3.21	$ 1,029.200 Millions	$ 320.600 Millions
Ufp Technologies Inc	3.15	$ 29.849 Millions	$ 9.465 Millions
Antares Pharma Inc	3.13	$ 31.369 Millions	$ 10.009 Millions
Lemaitre Vascular Inc	3.09	$ 20.132 Millions	$ 6.520 Millions
Event Cardio Group Inc.	3.09	$ 0.004 Millions	$ 0.001 Millions
Plus Therapeutics Inc	2.83	$ 36.922 Millions	$ 13.065 Millions
Tandem Diabetes Care Inc	2.68	$ 90.279 Millions	$ 33.633 Millions
Stryker Corp	2.52	$ 5,931.000 Millions	$ 2,353.000 Millions
Anika Therapeutics Inc	2.46	$ 35.777 Millions	$ 14.538 Millions
Nuwellis Inc	2.31	$ 6.563 Millions	$ 2.835 Millions
Edwards Lifesciences Corporation	2.18	$ 729.800 Millions	$ 335.200 Millions
Teleflex Incorporated	2.16	$ 584.088 Millions	$ 271.007 Millions
Apyx Medical Corp	2.04	$ 4.880 Millions	$ 2.389 Millions
Utah Medical Products Inc	2.01	$ 3.818 Millions	$ 1.903 Millions
Becton Dickinson And Company	1.99	$ 3,191.104 Millions	$ 1,606.374 Millions
Bionik Laboratories Corp	1.98	$ 0.012 Millions	$ 0.006 Millions
Cardiovascular Systems Inc	1.85	$ 24.558 Millions	$ 13.270 Millions
Iridex Corp	1.73	$ 10.789 Millions	$ 6.250 Millions
Masimo Corp	1.71	$ 129.882 Millions	$ 75.953 Millions

Date modified: 2026-09-08T17:29:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.